Neurent Medical has opened a new, state-of-the-art manufacturing plant in Oranmore, Co. Galway, Ireland, to serve as the central hub for production of its Neuromark system. Neuromark recently received FDA clearance for treating chronic rhinitis.
The system optimizes treatment of posterior nasal nerves with real-time feedback, precise electrode placement, and impedance-controlled low-power radiofrequency energy to reduce nasal congestion and rhinorrhea.
The new facility represents a major investment in Galway’s medtech ecosystem, expected to create 125 skilled jobs by 2028 across engineering, quality, operations, supply chain, and sales.
CEO Brian Shields emphasized the importance of local manufacturing to meet growing demand, maintain quality, and deliver Irish-engineered innovation globally.
Follow MEDWIRE.AI for updates on medtech manufacturing and innovation.
